High Vista Strategies LLC Point Biopharma Global Inc. Call Options Transaction History
High Vista Strategies LLC
- $249 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding PNT
# of Institutions
1Shares Held
20KCall Options Held
0Put Options Held
0About POINT Biopharma Global Inc.
- Ticker PNT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 104,025,000
- Description
- POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...